Albuquerque, NM
Stem Cell Therapy clinics in Albuquerque
Albuquerque supports a regenerative medicine market shaped by both private clinics and regional academic medicine. Local referral networks run through University of New Mexico Hospital and Presbyterian, and stem cell practice in the area spans Uptown, Northeast Heights, and the Journal Center. Patient demand splits across three buckets: orthopedic injections for active adults and aging athletes, neurological and autoimmune protocols marketed to longevity-focused patients, and IV-based allogeneic products offered by private wellness clinics. The FDA classifies most stem cell injections for orthopedic, neurological, or longevity use as investigational biologics under 21 CFR Part 1271, meaning they require either a Biologics License or an active Investigational New Drug authorization. Autologous bone marrow and adipose products may qualify as Section 361 when minimally manipulated and used for homologous function. New Mexico regulates physician practice through the Medical Board. There is no state-specific stem cell statute, so federal 21 CFR Part 1271 rules apply. The 17 Albuquerque clinics listed below have been reviewed against our vetting criteria, including federal NPI lookup, OIG exclusion screening, and New Mexico Medical Board licensure checks.
Round 2 IV Wellness Solutions
- Stem Cell Therapy
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- IV Therapy
La Vida Sana Medical Spa
- PRP Therapy
- Arthritis Treatment
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
- Stem Cell Therapy
Manzano Medical Group
- PRP Therapy
- Shockwave Therapy
- Laser Therapy (LLLT)
- Arthritis Treatment
- Stem Cell Therapy
Round 2 Wellness - Concierge Primary Care
- Stem Cell Therapy
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- IV Therapy
PCI Vein & Pain Consultant
- Arthritis Treatment
- Hormone Replacement Therapy (HRT)
- Stem Cell Therapy
Regulatory context
A note on New Mexico's stem cell therapy rules.
New Mexico cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in New Mexico for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. New Mexico's regulatory environment relies on federal law and the Medical Practice Act.
-
New Mexico Medical Practice Act, NMSA Chapter 61, Article 6
Establishes physician licensure and discipline through the New Mexico Medical Board. -
New Mexico Naturopathic Doctor Practice Act
Provides registration for naturopathic doctors with limited scope; cellular biologic injections are generally outside formulary. -
New Mexico Pharmacy Act, NMSA Chapter 61, Article 11
Regulates compounding pharmacies aligned with federal 503A and 503B standards.
The FDA has corresponded with New Mexico providers offering cellular therapies. The New Mexico Medical Board has authority to discipline physicians for unprofessional conduct including misleading regenerative medicine advertising. The New Mexico Attorney General can pursue deceptive marketing under the New Mexico Unfair Practices Act. New Mexico's smaller market means enforcement is less frequent than in larger states, but federal warning letters apply nationally.